Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Texas at Austin
Aim 1: Test the hypothesis that men administered testosterone nasal spray will result in lower levels of anxiety (anticipatory and situational) and greater levels of approach behavior in response to two distinct (social and nonsocial) anxiety challenges relative to men administered placebo spray.
Aim 2: Test the hypothesis that anxiety challenge type (social versus nonsocial) will moderate the effects of testosterone administration on subjects' responses to challenge.
Aim 3: Test the hypothesis that rejection sensitivity - heightened sensitivity to evaluative threat - will moderate the effects of drug condition on response to the two anxiety challenge tests.
Age
18–any
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Male, 18 years of age or older
You may not be if
Male breast cancer
Obstructive sleep apnea
Suspected or diagnosed prostate cancer
Male breast cancer
Obstructive sleep apnea
Diabetes
Heart Disease
Liver disease (e.g., hepatitis)
Kidney disease
Thyroid disease
Tuberculosis or history if positive TB test
Infection or fever in the past 7 days
Surgeries within the last 6 weeks
Anemia
Gastrointestinal disease
Respiratory disease (e.g., asthma or chronic bronchitis)
